James M. Strickland is Director at IMARX THERAPEUTICS INC (IMRX). They have made 1 open-market trade across 1 company since 2007, most recently 2009-08-21.
CIK 0001373932
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2007, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMRX | BUY | 2007-07-26 | 2007-07-30 | $5.00 | $10K | +55.1% | -9.8% | -9.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.